These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10645753)

  • 1. Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg.
    Bekersky I; Dressler D; Mekki QA
    Clin Ther; 1999 Dec; 21(12):2058-64. PubMed ID: 10645753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design.
    Bekersky I; Dressler D; Colburn W; Mekki Q
    J Clin Pharmacol; 1999 Oct; 39(10):1032-7. PubMed ID: 10516937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose.
    Bekersky I; Dressler D; Mekki Q
    J Clin Pharmacol; 2001 Mar; 41(3):289-97. PubMed ID: 11269569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
    Undre N; Dickinson J
    BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects.
    Bekersky I; Dressler D; Mekki QA
    J Clin Pharmacol; 2001 Feb; 41(2):176-82. PubMed ID: 11210398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
    Sansone-Parsons A; Krishna G; Martinho M; Kantesaria B; Gelone S; Mant TG
    Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial.
    Arns W; Huppertz A; Rath T; Ziefle S; Rump LC; Hansen A; Budde K; Lehner LJ; Shipkova M; Baeumer D; Kroeger I; Sieder C; Klein T; Schenker P
    Transplantation; 2017 Nov; 101(11):2780-2788. PubMed ID: 28658202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence studies of tacrolimus capsule under fasting and fed conditions in healthy male and female subjects.
    Lainesse A; Hussain S; Monif T; Reyar S; Tippabhotla SK; Madan A; Thudi NR
    Arzneimittelforschung; 2008; 58(5):242-7. PubMed ID: 18589558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study.
    Solari S; Cancino A; Wolff R; Norero B; Vargas JI; Barrera F; Guerra JF; Martínez J; Jarufe N; Soza A; Arrese M; Benitez C
    Aliment Pharmacol Ther; 2017 May; 45(9):1225-1231. PubMed ID: 28261844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual tacrolimus: a pharmacokinetic evaluation pilot study.
    Tsapepas D; Saal S; Benkert S; Levine D; Delfin M; Cremers S; Amann S; Dadhania D; Kapur S; Aull M
    Pharmacotherapy; 2013 Jan; 33(1):31-7. PubMed ID: 23307542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prograf five milligrams versus Tacrolimus medis in healthy volunteers: a bioequivalence study.
    Masri M; Rizk S; Boujbel L; Bellahirich W; Baassoumi D; Attia M; Matha V
    Transplant Proc; 2013; 45(10):3453-7. PubMed ID: 24314930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of two tacrolimus formulations under fasting conditions in healthy male subjects.
    Mathew P; Mandal J; Patel K; Soni K; Tangudu G; Patel R; Kale P
    Clin Ther; 2011 Sep; 33(9):1105-19. PubMed ID: 21840601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of potential pharmacokinetic interaction between sirolimus and tacrolimus in healthy volunteers.
    Tortorici MA; Parks V; Matschke K; Korth-Bradley J; Patat A
    Eur J Clin Pharmacol; 2013 Apr; 69(4):835-42. PubMed ID: 23052408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations.
    van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N
    Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative tacrolimus pharmacokinetics: normal versus mildly hepatically impaired subjects.
    Bekersky I; Dressler D; Alak A; Boswell GW; Mekki QA
    J Clin Pharmacol; 2001 Jun; 41(6):628-35. PubMed ID: 11402631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects.
    Bifano M; Adamczyk R; Hwang C; Kandoussi H; Marion A; Bertz RJ
    Clin Drug Investig; 2015 May; 35(5):281-9. PubMed ID: 25896946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
    Nasiri-Toosi Z; Dashti-Khavidaki S; Nasiri-Toosi M; Khalili H; Jafarian A; Irajian H; Abdollahi A; Sadrai S
    Exp Clin Transplant; 2012 Dec; 10(6):586-91. PubMed ID: 22770208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.